The GOG Highlight Reel – November 2022
Activity Overview
The GOG Foundation, Inc. and GOG Partners is thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that will showcase clinical trials and other newsworthy education, from major medical meetings throughout the year.
This educational event will take place twice in a calendar year, with the November 2022 highlight reel program presented virtually on Friday, November 11, 2022 from 11:00 am – 2:00 pm ET. The GOG Foundation, Inc. and GOG Partners will share a recap outlining major medical advancements in Gynecologic Oncology through discussion and presentation of the abstracts presented during some of the best oncology and women’s cancer meetings.
This engaging session will bring together the brightest minds and world-renown researchers. Didactic presentations, debates and expert panel discussions will have you and your colleagues on the edge of your seat, as our clinical experts share best practice and ways to improve the standard of care in gynecologic malignancies. The GOG Leadership will also present Trials In Progress.
The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: AstraZeneca, Seagen, Karyopharm, Mersana, Laekna Therapeutics and Immunogen.
Target Audience
The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.
Learning Objectives
Upon completion of the activities in this series, learners will demonstrate:
Increased knowledge regarding:
-
- The current agents and regimens used in treating advanced, persistent, or recurrent cervical, endometrial, and ovarian cancers
- The key trial data for newer therapies in treating advanced, persistent, or recurrent cervical, endometrial, and ovarian cancers
- The current investigational agents and regimens under evaluation for the treatment of advanced, persistent, or recurrent cervical, endometrial, and ovarian cancers
Greater competence related to:
-
- Selecting therapies and treatments for women with cervical, endometrial, and ovarian cancers
Moderators
Dr. Bradley Monk
Dr. Robert Coleman
Faculty
Dr. Ramez Eskander
Dr. Thomas Herzog
Dr. David O’Malley
Dr. Kathleen Moore
Dr. Bhavana Pothuri
Dr. Leslie Randall
Dr. Angeles Secord
Dr. Brian Slomovitz
Agenda & Presentation Materials
The GOG Highlight Reel Educational Series – November 2022
Presented on Friday, November 11, 2022, 11:00 am – 2:00 pm ET
Enduring Educational Materials will be available on demand for six months following the live virtual presentation.
To access the recording of this symposium, please click the button below. Once you have completed the registration, a confirmation email will be sent to the email address you provide and will include a link to access the recording. To view the presentation slides, you may click the View Presentation links in the agenda below.
Register To Access the Symposium Recording
Larry J. Copeland, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
Bradley Monk, MD, Director, University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital and HonorHealth Phoenix, Arizona, USA
Robert Coleman, MD, US Oncology Research, Houston, Texas, USA
Angeles Alvarez Secord, MD, MHSc, Director of Gynecologic Oncology Clinical Trials, Duke Cancer Center Institute, Durham, North Carolina, USA
Bhavana Pothuri, MD, NYU Langone, New York City, New York, USA
Ramez Eskander, MD, UC San Diego, San Diego, California, USA
Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, Oklahoma, USA
Leslie Randall, MD, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA
Brian Slomovitz, MD, Mount Sinai Medical Center, Miami Beach, Florida, USA
Bradley Monk, MD, Director, University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital and HonorHealth Phoenix, Arizona, USA
Robert Coleman, MD, US Oncology Research, Houston, Texas, USA
Continuing Education
In support of improving patient care, this activity has been planned and implemented by The GOG Foundation, Inc. (GOG).
Accreditation Statement
The GOG Foundation, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.
AMA PRA Category 1 Credits™
The GOG Foundation, Inc. designates this on demand activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in and receiving CME credit for this activity. Participants must: 1) read the educational objectives and faculty disclosures; 2) attend the educational activity; 3) email our educational team at info@gog.org to receive and complete the educational evaluation.
Participants who complete the educational activity and evaluation will receive a certificate of credit.
Disclosure Declaration
In accordance with the ACCME Accreditation Criteria, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any ineligible company *(formally known as commercial interests). All Committee/Planning/Faculty members were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. All relevant financial relationships listed for these individuals have been mitigated to ensure a bias-free presentation. Please see the faculty disclosure list for detailed information.
- Bradley Monk, MD, Director, Principal Investigator, Community Research Development, HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph’s Hospital Phoenix, Arizona, USA
- Robert Coleman, MD, US Oncology Research, Houston, Texas, USA
- Brian Slomovitz, MD, Mount Sinai Medical Center, Miami Beach, Florida, USA
- Leslie Randall, MD, Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA
- David O’Malley, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
- Kathleen Moore, MD, Stephenson Cancer Center, Oklahoma City, Oklahoma, USA
- Ramez Eskander, MD, UC San Diego, San Diego, California, USA
- Angeles Alvarez Secord, MD, MHSc, Director of Gynecologic Oncology Clinical Trials, Duke Cancer Center Institute, Durham, North Carolina, USA
- Bhavana Pothuri, MD, NYU Langone, New York City, New York, USA
- Thomas J. Herzog, MD, University of Cincinnati, Cincinnati, Ohio, USA
Technical Requirements
This virtual activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.